Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XII.b

Pericardial effusion (w/wo tamponade)

Pericarditis (i.e. pericardial inflammation) is usually heralded by acute mediothoracic chest pain (PMID 10878205). Large effusions can be ANA positive and cause pericardial tamponade. When present as a longterm sequela, pericardial thickening may cause restriction and constriction. See also under Vc, d, g, m and XIIk (PMID 20511488, 23376916)

Publications

Vittorio A, Sharma R, Siejka D, Bhattarai K, Hardikar A

Recurrent Pericardial Effusion While Receiving Nivolumab for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature.

Clinical lung cancer 2018 09;19;e717-e720 — 2018 09 — e717-e720

de Almeida DVP, Gomes JR, Haddad FJ, Buzaid AC

Immune-mediated Pericarditis With Pericardial Tamponade During Nivolumab Therapy.

Journal of immunotherapy (Hagerstown, Md. : 1997) 2018 09;41;329-331 — 2018 09 — 329-331

Kushnir I, Wolf I

Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion.

Cardiology 2017;136;49-51 — 2017 — 49-51

Nesfeder J, Elsensohn AN, Thind M, Lennon J, Domsky S

Pericardial effusion with tamponade physiology induced by nivolumab.

International journal of cardiology 2016 Nov 01;222;613-614 — 2016 Nov 01 — 613-614